Egyptian International Pharmaceutical Industries Company reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was EGP 992.42 million compared to EGP 927.37 million a year ago. Net income was EGP 188.26 million compared to EGP 173.47 million a year ago.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
41.81 EGP | -3.17% | -7.05% | +14.55% |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+14.55% | 130M | |
+19.62% | 43.34B | |
+20.44% | 21.96B | |
+10.86% | 14.09B | |
+13.07% | 13.64B | |
+37.46% | 11.43B | |
-8.59% | 6.86B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+8.46% | 5.22B |
- Stock Market
- Equities
- PHAR Stock
- News Egyptian International Pharmaceutical Industries Company
- Egyptian International Pharmaceutical Industries Company Reports Earnings Results for the First Quarter Ended March 31, 2023